The purpose of this study was to compare the performance of anti-factor Xa concentration versus activated partial thromboplastin time (aPTT) monitoring with multiple indication-specific heparin nomograms. This was a prospective, nonrandomized study with historical control at a large academic medical center. A total of 201 patients who received intravenous heparin in the cardiology units were included. The prospective cohort included patients (n = 101) with anti-factor Xa (anti-Xa) monitoring, and the historical control group included patients (n = 100) who had aPTT monitoring. Patients in the prospective group had both anti-Xa and aPTT samples drawn, but anti-Xa was used for dosing adjustment. The anti-Xa cohort achieved a significantly faster time to therapeutic range ( P < .01) and required fewer dose adjustments per 24-hour period compared to the aPTT control ( P = .01). Results were consistent across heparin nomograms. The overall discordance rate between the 2 tests was 49%. No significant differences in clinical outcomes were observed. In summary, anti-Xa monitoring improved the time to therapeutic anticoagulation and led to fewer dose adjustments compared to the aPTT with multiple indication-based heparin nomograms.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714688 | PMC |
| http://dx.doi.org/10.1177/1076029617741363 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Establishment and validation of a predictive model for lower extremity deep vein thrombosis in patients with traumatic pelvic fractures.
Thromb J
November 2024
Department of Emergency Medicine, The Sixth People's Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200233, China.
Background: Patients with traumatic pelvic fracture (TPF) are at high risk for developing deep vein thrombosis (DVT). However, there is still no unified standard on how to distinguish high-risk groups for DVT in patients with TPF and how to accurately use anticoagulants at present.
Objectives: This observational study aimed to establish a DVT risk nomogram score (DRNS) model for TPF patients, and to explore the value of the DRNS model as a clinical guideline in the prevention of DVT with low molecular weight heparin (LMWH).
Development of a risk prediction model for the first occurrence of thrombosis in patients with OAPS.
Front Immunol
October 2024
Department of Clinical Immunology, Xijing Hospital, The Fourth Military Medical University, Xi'an, China.
Article Synopsis
- The study aims to identify risk factors for thrombotic events in obstetric antiphospholipid syndrome (OAPS) patients and create a predictive model specifically for postpartum thrombosis in those without previous thrombotic history.
- A retrospective analysis was performed on 269 OAPS patients, evaluating various clinical and laboratory factors to determine which could best predict thrombosis risk, ultimately leading to the development of a nomogram.
- Findings showed that 32.58% of retrospective patients developed thrombosis after three years, with key risk indicators being low platelet count, multiple positive antiphospholipid antibodies, and the use of specific post-delivery medications.
Management of Therapeutic-intensity Unfractionated Heparin: A Narrative Review on Critical Points.
TH Open
July 2024
Department of Laboratory Hematology, Pontchaillou University Hospital of Rennes, France.
Nowadays, unfractionated heparin (UFH) use is limited to selected patient groups at high risk of both bleeding and thrombosis (patients in cardiac surgery, in intensive care unit, and patients with severe renal impairment), rendering its management extremely challenging, with many unresolved questions despite decades of use. In this narrative review, we revisit the fundamental concepts of therapeutic anticoagulation with UFH and address five key points, summarizing controversies underlying the use of UFH and discussing the few recent advances in the field: (1) laboratory tests for UFH monitoring have significant limitations; (2) therapeutic ranges are not well grounded; (3) the actual influence of antithrombin levels on UFH's anticoagulant activity is not well established; (4) the concept of UFH resistance lacks supporting data; (5) scarce data are available on UFH use beyond acute venous thromboembolism. We therefore identified key issues to be appropriately addressed in future clinical research: (1) while anti-Xa assays are often considered as the preferred option, we call for a vigorous action to improve understanding of the differences between types of anti-Xa assays and to solve the issue of the usefulness of added dextran; (2) therapeutic ranges for UFH, which were defined decades ago using reagents no longer available, have not been properly validated and need to be confirmed or reestablished; (3) UFH dose adjustment nomograms require full validation.
View Article and Find Full Text PDFA predictive nomogram-based model for lower extremity compartment syndrome after trauma in the United States: a retrospective case-control study.
J Trauma Inj
June 2024
Department of Surgery, HCA Ocala Hospital, Ocala, FL, USA.
Article Synopsis
- * Researchers conducted a retrospective case-control study and utilized multivariable regression to find significant risk factors, resulting in a nomogram for prediction.
- * Key findings highlighted that specific medications like heparin and certain blood product transfusions were significant risk factors for developing ACS, with the proposed risk calculator aiding in identifying high-risk patients.
Low-Intensity Heparin Infusion Compared With High-Intensity Heparin Infusion Dosing in Patients With Mechanical Mitral Valves: A Retrospective Cohort Study.
J Cardiovasc Pharmacol
September 2024
University of Michigan Health, Ann Arbor, MI.
Patients with a mechanical mitral valve have an increased risk of thrombosis, and guidelines recommend a higher international normalized ratio goal for vitamin K antagonists-based anticoagulation. Guidelines provide recommendations for bridging with unfractionated heparin; however, there is no clear guidance on the heparin infusion intensity that should be used. This study was a retrospective, single-center, cohort study of patients aged ≥18 years or older with a mechanical mitral valve admitted from June 2019 to September 2022 who were maintained on a singular heparin infusion intensity nomogram for at least 48 hours.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!